尊敬的各位医学与材料专家及同仁：

     为进一步探讨实现中国介入医学材料及工程领域的创新驱动、转型发展的着力点和突破口，依托科技进步，促进学科渗透、专业融合、行业发展，推广新技术、新产品、新方案转化应用，推动我国介入医学材料及工程领域的技术进步及产学研的紧密结合。以干细胞治疗、血管腔内介入治疗为核心，以互联网+大数据为支撑，引领国内外干细胞与介入治疗的方向，联合国内外最新研究成果，推广临床治疗新技术、建立临床应用新标准、研发相关细胞与器械新产品。以“国家放射与治疗临床医学研究中心、中国介入医师分会介入材料工程与生物技术委员会、中国糖尿病足细胞与介入治疗技术联盟、中国生物医学工程学会、同济大学医学院介入血管研究所”作为主办单位，以同济大学介入血管研究所、同济大学附属第十人民医院、中国科技大附属第一医院、暨南大学附属珠海医院、安徽医科大学附属合肥医院、云南省滇南中心医院、生物医用材料改性国家地方联合工程实验室、血管植入物开发国家地方联合工程实验室、《介入医学杂志》英文版、上海市介入治疗质控中心、北京铭逸荟文化传媒有限公司“承办的“2020中国介入医学材料与工程学术论坛暨第七届中国糖尿病足细胞与介入治疗学术会议”定于2020年11月13-15日在上海举行。

     本次大会注重围绕：1) 中国介入医学材料科学及工程技术的创新、医学新材料的推广与临床应用；2) 糖尿病足细胞与介入技术的临床转化及应用；3) 介入医学材料与工程大数据研究及互联网应用；4) 发布介入新产品、前沿与临床治疗技术指南、专著；5) 介入医学相关新产品的介绍/推广；6）介入护理新进展。

大会组委会诚挚地邀请您的莅临，并衷心的希望各位专家代表畅所欲言，共商介入医学发展的战略和方针。让我们共同努力，为提高中国介入医学的诊疗技术和中国介入医学材料及工程的快速发展做出新的贡献。

   2020年8月

Dear experts and fellows:

To further explore the key points and breakthroughs for the innovation and transformation of China's interventional materials and engineering fields, promoting and relying on scientific and technological progress, discipline combined, professional integration, industry development and to promote the application of new technologies, new products, and new solutions, the fields of interventional materials and engineering are to be promoted for the close integration of technological advancement and production, study and research in China. Focusing on stem cell therapy and endovascular interventional therapy, with the support of Internet plus and big data, leading the direction of stem cells and interventional therapy and combining the latest research results in domestic and abroad fields, promoting new clinical treatment technologies, establishing new standards for clinical application, and developing the related new products of cells and devices, the level of cells and interventional treatment of diabetic vascular disease has been improved in China as a whole, which is at the leading position of the world. “The Forum of 2020 Chinese Interventional Materials and Engineering（CIME 2020）and the 6th China Diabetic Foot’s Cell and Interventional Therapy Conference（7^thCFCI）”, hosted by, the National Clinical Research Center of Interventional Medicine,the Chinese Society of Biomedical Engineering,  Institute of Interventional and Vascular, Tongji Medical School, Tongji University.The committee of Chinese interventional physicians on materials engineering and biotechnology, China Diabetes Foot Cell and Interventional Therapy Technology Alliance, etc., organized by Tenth People's Hospital Affiliated to Tongji University, National Local Joint Engineering Laboratory of Biomedical Material Modification, National Local Joint Engineering Laboratory for Vascular Implant Development ,etc., will be held in Shanghai from November, 13-15 .

The conference focuses on:

1) The innovation of interventional materials science and engineering technology, and the promotion and clinical application of new medical materials;

2) Clinical transformation and application of diabetic foot’s cell and interventional techniques;

3) Big data research and Internet applications of Interventional materials and engineering;

4) Publish Frontier and Clinical Therapeutic Technical Guidelines and Monographs

5) Promotion of new products related to interventional medicine.

6) Interventional nursing.

The Organizing Committee sincerely invites all the experts besides you to attend and hopes that youcan express your opinion freely and work together to make greater contributions to improving the diagnosis and treatment technology of Chinese interventional medicine and the increasing development of Chinese interventional materials and engineering.

  Honorary Chairmen: Junbo Ge, Anming Meng, Jianchen Fang, Zhaoshen Li, Guang Ning

General Chairmen: Ke Xu, Gaojun Teng, Yingshen Chen

Executive Chairman: Maoquan Li,Ligong Lu, Donglei Wu,Shuangli Xin,Shuangbin Yang,Zhiping,Yan,  Jijin Yang

Aug. 2020